Literature DB >> 21604

Detection of penumococcal antigens in the sputum in pneumococcal pneumonia.

R P Leach, J D Coonrod.   

Abstract

Forty-seven patients with bacterial pneumonia were grouped by use of clinical criteria according to the relative certainty of a diagnosis of pneumococcal pneumonia. Sputums were tested for pneumococcal antigens by counterimmunoelectrophoresis with polyvalent pneumococcal antiserum. Antigens were detected in the sputum of 29 of 39 patients with evidence of pneumococcal pneumonia, and there was good correlation between the detection of antigens and the degree of certainty of the clinical diagnosis. Antigens persisted briefly in the sputum during therapy with antimicrobial drugs and could be detected during the first 48 hours of therapy in most cases of pneumococcal pneumonia. Pneumococci were isolated from the sputum in only 18 of 39 cases of pneumococcal pneumonia, and sputum cultures did not correlate as well as counterimmunoelectrophoresis with clinical diagnoses. In studies of 27 patients with chronic bronchitis without pneumonia, pneumococci were isolated from sputum in 10 cases, whereas counterimmunoelectrophoresis was positive in 5 cases. Counterimmunoelectrophoresis provides a simple and rapid method for detecting pneumococcal antigens in sputum, and it appears to be more reliable than sputum cultures in establishing a presumptive diagnosis in pneumococcal pneumonia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 21604     DOI: 10.1164/arrd.1977.116.5.847

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

1.  Evaluation of a latex test for rapid detection of pneumococcal antigens in sputum.

Authors:  S Wellstood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

2.  Diagnosis of pneumococcal pneumonia by antigen detection in sputum.

Authors:  J Miller; M A Sande; J M Gwaltney; J O Hendley
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

3.  Comparison of sputum counterimmunoelectrophoresis and culture in diagnosis of pneumococcal pneumonia.

Authors:  B A Downes; P D Ellner
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

4.  Routine use of counterimmunoelectrophoresis for the detection of pneumococcal antigen in sputum.

Authors:  C H Ericsson; H O Hallander; A Rosen; A M Sjögren; I Sjögren
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

5.  Pneumococcal capsular antigen detection and pneumococcal serology in patients with community acquired pneumonia.

Authors:  W G Boersma; A Löwenberg; Y Holloway; H Kuttschrütter; J A Snijder; G H Koëter
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

6.  Detection of C polysaccharide in Streptococcus pneumoniae in the sputa of pneumonia patients by an enzyme-linked immunosorbent assay.

Authors:  H Holmberg; T Holme; A Krook; T Olsson; L Sjöberg; A M Sjögren
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

7.  Thermodissociation of staphylococcal immune complexes and detection of staphylococcal antigen in serum from patients with Staphylococcus aureus bacteremia.

Authors:  Z A Tabbarah; L J Wheat; R B Kohler; A White
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

8.  Coagglutination and counterimmunoelectrophoresis for detection of pneumococcal antigens in the sputum of pneumonia patients.

Authors:  E A Edwards; J D Coonrod
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

9.  Cross-reactions between alpha-streptococci and Omniserum, a polyvalent pneumococcal serum, demonstrated by direct immunofluorescence, immunoelectroosmophoresis, and latex agglutination.

Authors:  H Holmberg; D Danielsson; J Hardie; A Krook; R Whiley
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

10.  Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact.

Authors:  R A Garibaldi
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.